{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:36:37Z","timestamp":1790487397157,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["667837"],"award-info":[{"award-number":["667837"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002996","name":"Hartstichting","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.cmi.2019.06.002","type":"journal-article","created":{"date-parts":[[2019,6,15]],"date-time":"2019-06-15T19:06:30Z","timestamp":1560625590000},"page":"1479-1483","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Non-specific effects of BCG in protozoal infections: tegumentary leishmaniasis and malaria"],"prefix":"10.1016","volume":"25","author":[{"given":"J.C.","family":"dos Santos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Vilela Teodoro Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Ribeiro-Dias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.A.B.","family":"Joosten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2019.06.002_bib1","doi-asserted-by":"crossref","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2019.06.002_bib2","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.trsl.2013.03.006","article-title":"New vaccines for neglected parasitic diseases and dengue","volume":"162","author":"Beaumier","year":"2013","journal-title":"Transl Res"},{"key":"10.1016\/j.cmi.2019.06.002_bib3","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4269\/ajtmh.16-84256","article-title":"Diagnosis and treatment of leishmaniasis: clinical practice guidelines by the infectious diseases society of America (IDSA) and the American Society of tropical medicine and hygiene (ASTMH)","volume":"96","author":"Aronson","year":"2017","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.cmi.2019.06.002_bib4","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/nrmicro2608","article-title":"Leishmaniasis: complexity at the host-pathogen interface","volume":"9","author":"Kaye","year":"2011","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.cmi.2019.06.002_bib5","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(05)67629-5","article-title":"Advances in leishmaniasis","volume":"366","author":"Murray","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2019.06.002_bib6","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.idc.2012.03.001","article-title":"Cutaneous and mucocutaneous leishmaniasis","volume":"26","author":"Goto","year":"2012","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.cmi.2019.06.002_bib7","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.trstmh.2007.01.005","article-title":"First report of diffuse cutaneous leishmaniasis and Leishmania amazonensis infection in Rio de Janeiro State, Brazil","volume":"101","author":"Azeredo-Coutinho","year":"2007","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.cmi.2019.06.002_bib8","doi-asserted-by":"crossref","first-page":"901","DOI":"10.2217\/fmb.14.43","article-title":"Immunity to visceral leishmaniasis: implications for immunotherapy","volume":"9","author":"Khadem","year":"2014","journal-title":"Future Microbiol"},{"key":"10.1016\/j.cmi.2019.06.002_bib9","doi-asserted-by":"crossref","first-page":"2","DOI":"10.5070\/D39CT3H710","article-title":"Sensitivity of leishmanin skin test in patients of acute cutaneous leishmaniasis","volume":"12","author":"Manzur","year":"2006","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.cmi.2019.06.002_bib10","series-title":"World malaria report 2005","author":"Malaria","year":"2005"},{"key":"10.1016\/j.cmi.2019.06.002_bib11","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/ni.2961","article-title":"Nonspecific effects of neonatal and infant vaccination: public-health, immunological and conceptual challenges","volume":"15","author":"Aaby","year":"2014","journal-title":"Nat Immunol"},{"key":"10.1016\/j.cmi.2019.06.002_bib12","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/S0140-6736(18)30324-6","volume":"391","author":"Ashley","year":"2018","journal-title":"Malar Lancet"},{"key":"10.1016\/j.cmi.2019.06.002_bib13","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s430-001-8017-8","article-title":"Rodent malaria: the mouse as a model for understanding immune responses and pathology induced by the erythrocytic stages of the parasite","volume":"189","author":"Li","year":"2001","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.cmi.2019.06.002_bib14","doi-asserted-by":"crossref","first-page":"7011","DOI":"10.1073\/pnas.88.16.7011","article-title":"Production of interferon gamma, interleukin 2, interleukin 4, and interleukin 10 by CD4+ lymphocytes in\u00a0vivo during healing and progressive murine leishmaniasis","volume":"88","author":"Heinzel","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cmi.2019.06.002_bib15","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3389\/fcimb.2019.00105","article-title":"CD4+ T cell-dependent macrophage activation modulates sustained PS exposure on intracellular amastigotes of Leishmania amazonensis","volume":"9","author":"Wanderley","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.cmi.2019.06.002_bib16","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cyto.2013.12.016","article-title":"The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of human tegumentary leishmaniasis","volume":"66","author":"Oliveira","year":"2014","journal-title":"Cytokine"},{"key":"10.1016\/j.cmi.2019.06.002_bib17","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/9781118493816.ch14","article-title":"Antimalarial drug resistance","author":"Shah","year":"2016","journal-title":"Recent Adv Malar"},{"key":"10.1016\/j.cmi.2019.06.002_bib18","doi-asserted-by":"crossref","first-page":"5787","DOI":"10.1016\/j.vaccine.2006.05.008","article-title":"The antipoverty vaccines","volume":"24","author":"Hotez","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2019.06.002_bib19","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.15585\/mmwr.mm6645a3","article-title":"Global routine vaccination coverage, 2016","volume":"66","author":"Feldstein","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.cmi.2019.06.002_bib20","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3389\/fimmu.2012.00068","article-title":"Louis Pasteur, the father of immunology?","volume":"3","author":"Smith","year":"2012","journal-title":"Front Immunol"},{"key":"10.1016\/j.cmi.2019.06.002_bib21","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/ni.3031","article-title":"Molecular regulation of effector and memory T cell differentiation","volume":"15","author":"Chang","year":"2014","journal-title":"Nat Immunol"},{"key":"10.1016\/j.cmi.2019.06.002_bib22","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1189\/jlb.5RI0315-096R","article-title":"Trained innate immunity as underlying mechanism for the long-term, nonspecific effects of vaccines","volume":"98","author":"Blok","year":"2015","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.cmi.2019.06.002_bib23","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/cid\/cit790","article-title":"Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials","volume":"58","author":"Mangtani","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2019.06.002_bib24","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/infdis\/jir240","article-title":"Randomized trial of BCG vaccination at birth to low-birth-weight children: beneficial nonspecific effects in the neonatal period?","volume":"204","author":"Aaby","year":"2011","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cmi.2019.06.002_bib25","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/ije\/dyh392","article-title":"BCG vaccination scar associated with better childhood survival in Guinea-Bissau","volume":"34","author":"Roth","year":"2005","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.cmi.2019.06.002_bib26","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1016\/S0264-410X(03)00181-6","article-title":"BCG scar and positive tuberculin reaction associated with reduced child mortality in West Africa: a non-specific beneficial effect of BCG?","volume":"21","author":"Garly","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2019.06.002_bib27","doi-asserted-by":"crossref","first-page":"405","DOI":"10.7326\/0003-4819-76-3-405","article-title":"Immunological effects of BCG in malignant melanoma: two modes of administration compared","volume":"76","author":"Bluming","year":"1972","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cmi.2019.06.002_bib28","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1464-410X.2012.11754.x","article-title":"Bacillus Calmette-Gu\u00e9rin immunotherapy for genitourinary cancer","volume":"112","author":"Gandhi","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.cmi.2019.06.002_bib29","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/cas.12075","article-title":"Bacillus Calmette-Guerin (BCG) immunotherapy for bladder cancer: current understanding and perspectives on engineered BCG vaccine","volume":"104","author":"Kawai","year":"2013","journal-title":"Cancer Sci"},{"key":"10.1016\/j.cmi.2019.06.002_bib30","doi-asserted-by":"crossref","first-page":"17237","DOI":"10.1073\/pnas.1202870109","article-title":"Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes","volume":"109","author":"Kleinnijenhuis","year":"2012","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.cmi.2019.06.002_bib31","doi-asserted-by":"crossref","first-page":"e0006164","DOI":"10.1371\/journal.pntd.0006164","article-title":"Changing demographics of visceral leishmaniasis in northeast Brazil: lessons for the future","volume":"12","author":"Lima","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.cmi.2019.06.002_bib32","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.3389\/fimmu.2018.02869","article-title":"Non-specific effects of vaccines illustrated through the BCG example: from observations to demonstrations","volume":"9","author":"Uthayakumar","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.cmi.2019.06.002_bib33","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1016\/j.celrep.2016.11.011","article-title":"Immunometabolic pathways in BCG-induced trained immunity","volume":"17","author":"Arts","year":"2016","journal-title":"Cell Rep"},{"key":"10.1016\/j.cmi.2019.06.002_bib34","doi-asserted-by":"crossref","first-page":"89 e5","DOI":"10.1016\/j.chom.2017.12.010","article-title":"BCG vaccination protects against experimental viral infection in humans through the induction of cytokines associated with trained immunity","volume":"23","author":"Arts","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.cmi.2019.06.002_bib35","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1002\/eji.1830241140","article-title":"Deficient expression of co-stimulatory molecules on Leishmania-infected macrophages","volume":"24","author":"Kaye","year":"1994","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.cmi.2019.06.002_bib36","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1084\/jem.177.1.145","article-title":"Signal transduction in host cells by a glycosylphosphatidylinositol toxin of malaria parasites","volume":"177","author":"Schofield","year":"1993","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.cmi.2019.06.002_bib37","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0140-6736(87)90116-4","article-title":"Immunotherapy versus chemotherapy in localised cutaneous leishmaniasis","volume":"1","author":"Convit","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2019.06.002_bib38","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/infdis\/160.1.104","article-title":"Immunotherapy of localized, intermediate, and diffuse forms of American cutaneous leishmaniasis","volume":"160","author":"Convil","year":"1989","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cmi.2019.06.002_bib39","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1590\/S0074-02762004000100010","article-title":"Therapy\u00a0of Venezuelan patients with severe mucocutaneous or early lesions of diffuse cutaneous leishmaniasis with a vaccine containing pasteurized Leishmania promastigotes and Bacillus Calmette-Guerin - preliminary report","volume":"99","author":"Convit","year":"2004","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.cmi.2019.06.002_bib40","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1365-3024.1989.tb00660.x","article-title":"Cell-mediated immunity in localized cutaneous leishmaniasis patients before and after treatment with immunotherapy or chemotherapy","volume":"11","author":"Castes","year":"1989","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.cmi.2019.06.002_bib41","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1046\/j.1365-3024.2000.00278.x","article-title":"Immunotherapy with live BCG plus heat killed Leishmania induces a T helper 1-like response in American cutaneous leishmaniasis patients","volume":"22","author":"Cabrera","year":"2000","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.cmi.2019.06.002_bib42","doi-asserted-by":"crossref","first-page":"378","DOI":"10.4269\/ajtmh.2009.81.378","article-title":"Case report: increase of NK cells and proinflammatory monocytes are associated with the clinical improvement of diffuse cutaneous leishmaniasis after immunochemotherapy with BCG\/Leishmania antigens","volume":"81","author":"Pereira","year":"2009","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.cmi.2019.06.002_bib43","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1590\/S0037-86822006000100003","article-title":"Immunotherapy, immunochemotherapy and chemotherapy for American cutaneous leishmaniasis treatment","volume":"39","author":"Mayrink","year":"2006","journal-title":"Rev Soc Bras Med Trop"},{"key":"10.1016\/j.cmi.2019.06.002_bib44","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0264-410X(02)00458-9","article-title":"The role of BCG in human immune responses induced by multiple injections of autoclaved Leishmania major as a candidate vaccine against leishmaniasis","volume":"21","author":"Alimohammadian","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.cmi.2019.06.002_bib45","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1046\/j.1365-2249.2003.02299.x","article-title":"Immune response measured in human volunteers vaccinated with autoclaved Leishmania major vaccine mixed with low dose of BCG","volume":"134","author":"Mahmoodi","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.cmi.2019.06.002_bib46","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/259309a0","article-title":"Protection of mice against babesia, and Plasmodium with BCG","volume":"259","author":"Clark","year":"1976","journal-title":"Nature"},{"key":"10.1016\/j.cmi.2019.06.002_bib47","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1128\/iai.33.1.199-211.1981","article-title":"Host defenses in murine malaria: nonspecific resistance to Plasmodium berghei generated in response to Mycobacterium bovis infection or Corynebacterium parvum stimulation","volume":"33","author":"Murphy","year":"1981","journal-title":"Infect Immun"},{"key":"10.1016\/j.cmi.2019.06.002_bib48","doi-asserted-by":"crossref","first-page":"e66115","DOI":"10.1371\/journal.pone.0066115","article-title":"Molecular analysis of non-specific protection against murine malaria induced by BCG vaccination","volume":"8","author":"Parra","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cmi.2019.06.002_bib49","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/s41467-019-08659-3","article-title":"Outcomes of controlled human malaria infection after BCG vaccination","volume":"10","author":"Walk","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.cmi.2019.06.002_bib50","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.4049\/jimmunol.1701010","article-title":"Cutting edge: Plasmodium falciparum induces trained innate immunity","volume":"200","author":"Schrum","year":"2018","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.cmi.2019.06.002_bib51","doi-asserted-by":"crossref","first-page":"i6091","DOI":"10.1136\/bmj.i6091","article-title":"Potential role for BCG in treatment of autoimmune diseases","volume":"355","author":"Curtis","year":"2016","journal-title":"BMJ"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X19302927?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X19302927?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:23:02Z","timestamp":1761117782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X19302927"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":51,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S1198743X19302927"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2019.06.002","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-specific effects of BCG in protozoal infections: tegumentary leishmaniasis and malaria","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2019.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}